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ABSTRACT
Aim: Inhalant abuse is a prevalent and often overlooked form
of substance abuse in adolescents. Chronic inhalant abuse
can damage respiratory, cardiac, renal, hepatic, and neurolog-
ic systems. This study aims to determine the physiologic
effects of inhaling solvents on the respiratory functions. 
Methods: The general health status of the subjects was assessed
by history taking, physical examination and a questionnaire
which was designed to show the severity of respiratory symp-
toms. Spirometry, ventilation/perfusion scintigraphy, and high
resolution computed tomography (HRCT) were performed to
assess pulmonary functions and anatomy.
Results: Thirty-one male volatile substance abusers and 19
control subjects were included in the study. The mean age of
onset of inhalant use was 14.6 ± 2.2 (9-18) years and dura-
tion of drug use was 3.7 ± 1.7 years. The most common respi-
ratory symptoms in volatile substance abusers were nasal
congestion (45.2%), sputum (38.7%), exercise intolerance
(32.3%) and cough (22.6%). Results of spirometric studies
showed 12 (41.4%) subjects with low FVC values < 80% of
predicted, indicative of restrictive ventilatory pattern in the
study group. Although the difference was not statistically sig-
nificant, restrictive ventilatory pattern was higher in the
study group. There was no statistically significant correlation
between restrictive ventilatory pattern and the age of
onset/duration/frequency of inhalant abuse, respiratory
symptoms and scintigraphic abnormalities. Subjects who had
restrictive pattern in their pulmonary function tests were
more likely to have abnormal findings at HRCT (p < 0.01).
Conclusion: This study has shown a positive correlation
between volatile substance abuse and the development of
restrictive ventilatory pattern, but more comprehensive stud-
ies are needed for more precise conclusions.
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RIASSUNTO 
Scopo: Negli adolescenti l’abuso di inalanti è una forma ad al-
ta prevalenza di abuso di sostanze, ma spesso è trascurato.
Può danneggiare l’apparato respiratorio, cardiaco, renale, epa-
tico ed il sistema nervoso. Questo studio cerca di determinare
gli effetti fisiologici dell’inalazione di solventi sull’apparato
respiratorio.
Metodi: Le condizioni generali dei soggetti sono state valuta-
te con l’anamnesi, l’esame obiettivo ed un questionario pro-
gettato per identificare la gravità dei sintomi respiratori. Per
valutare la funzionalità respiratoria e gli aspetti morfologici
sono state effettuate spirometria, scintigrafia ventilo/per-
fusoria ed una TAC toracica ad alta risoluzione (HRCT).
Risultati: Sono stati inclusi nello studio 31 maschi che abu-
savano di sostanze volatili e 19 soggetti di controllo. L’età
media dell’inizio dell’abuso di inalanti era 14,6 ± 2,2 (9-18)
anni e la durata dell’uso di droga era 3,7 ± 1,7 years. I sin-
tomi più comuni dell’abuso di sostanze volatili erano: con-
gestione nasale (45,2%), espettorato (38,7%), intolleranza
allo sforzo (32,3%) e tosse (22,6%). I risultati degli studi
spirometrici hanno identificato 12 (41,4%) soggetti con
bassi valori di capacità vitale forzata (< 80% del teorico),
suggestivi per un pattern restrittivo. Nonostante la diffe-
renza non fosse significativa il pattern ventilatorio restrit-
tivo era maggiore nel gruppo oggetto dello studio. Il pat-
tern ventilatorio restrittivo non era statisticamente corre-
lato con l’età di inizio, la durata o la frequenza dell’abuso di
inalanti, con i sintomi respiratori e con le anomalie scinti-
grafiche. I soggetti con deficit restrittivo avevano tuttavia
una maggiore frequenza di reperti patologici alla HRCT 
(p < 0,01).
Conclusioni: Questo studio mostra una correlazione positi-
va tra abuso di sostanze volatili e sviluppo di un deficit re-
spiratorio restrittivo, ma sono necessari studi più approfondi-
ti per ottenere dati conclusivi più accurati.
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INTRODUCTION 
Volatile substance abuse (VSA) is an especially im-
portant problem, because inhalants are daily-used
substances, the age of onset of VSA is early, and acts
as a gateway toward abuse of more dangerous sub-
stances. Inhalants are thought to be the first sub-
stances which children abuse; especially because
inhalants are cheap, easily accessible, legally freely
sold, in a packaging suitable for use, and have a
quick impact [1,2]. Inhalants are volatile hydrocar-
bons such as toluene, n-hexane, methyl butyl ke-
tone, trichlorethylene, trichlorethane, dichloro -
methane, gasoline and butane. 
In Turkey, the most widely used inhalants are paint
thinners, and glues [3]. Because of the highly
lipophilic character of inhalants, their use exerts
harmful effects on various systems, and primarily on
the nervous system. The most important acute effect
of volatiles is sudden death, which is thought to de-
velop as a result of vagal inhibition, anoxia, respira-
tory failure, and cardiac arrhythmia [3,4]. Long-
term low-dose volatile substance abuse may cause
nervous system damage, such as muscle weakness,
tremor, peripheral neuropathy, cerebellar dysfunc-
tion, chronic encephalopathy, and dementia [5-8].
In addition, there are also non-neurologic compli-
cations such as congestive heart failure, distal renal
tubular acidosis, metabolic acidosis with high an-
ion gap, Fanconi syndrome, nephrolithiasis,
glomerulonephritis, Goodpasture's syndrome, toxic
hepatitis, reversible hepatorenal failure, leukemia,
and aplastic anemia [8].
VSA is a problem which is gaining importance in
children and young adults of developed nations,
along with developing nations. A research conducted
by the United Nations Office on Drugs and Crime
(UNODC) found the age of onset to be 11 for in-
halants, 16 for cannabis, and 17 for ecstasy [9].
Therefore, it is necessary to investigate the effects of
abuse of inhalants on health, and to inform and edu-
cate these children, their families, and society in gen-
eral. Inhalants are widely abused and have many
known adverse effects; but there are few published
clinical research studies in the literature to date inves-
tigating the long-term pulmonary toxicity of volatile
inhalants. In this study, we aimed to determine the
physiologic effects of inhaling solvents on the respira-
tory functions of the adolescent inhalant abusers. 
MATERIALS AND METHODS
This is a case-control study, conducted between
November 2006 and November 2007, as a joint
collaboration between Ege University Faculty of
Medicine, Department of Pediatrics, Division of
Pulmonology and Allergy, and Ege University Child
and Adolescent Addiction Investigation and
Practice Center (EGEBAM). The approval of the
Institutional Ethics Committee of Ege University
Faculty of Medicine was obtained before the initia-
tion of study.
Study group
The subject group of this study were the individuals
undergoing inpatient treatment at the Ege
University Child and Adolescent Addiction
Investigation and Practice Center (EGEBAM).
Criteria for inclusion in the study were that subjects:
i) met the diagnostic criteria of DSM-IV-TR inhalant-
related disorders; and ii) were able to cooperate in
the study, by responding to questions, and undergo-
ing the necessary examinations. Exclusion criteria
were: i) a history of chronic systemic illness, or as-
suming a pharmaceutical drug for this type of ill-
ness, in the period before the development of sus-
tance abuse; ii) presence of a psychological disor-
der, at a level which would not allow participating
in, or continuing with the study.
A total of 31 volatile substance abusers were admit-
ted to the study. The age range of the patient group
was 13-21 years. The control group comprised 19
subjects, selected from adolescents who had no
health problem and who did not abuse any sub-
stance. All of the subjects who met the criteria for
inclusion in the study, and their parents, were in-
formed both verbally and in writing. After this, a
questionnaire was administered that probed their
sociodemographic characteristics, and respiratory
system complaints. Detailed physical examination
of all the subjects was performed. The severity of in-
halant abuse was assessed, by a psychiatrist experi-
enced in substance abuse disorders, by administer-
ing YUKUD (Yeniden Adolescent Inhalant Use
Severity Scale), which consists of 18 questions.
Subjects underwent a pulmonary function test, ven-
tilation-perfusion scintigraphy, and high-resolution
computerized tomography (HRCT). 
Statistical evaluation
Statistical analyses were performed using “SPSS
(Statistical Package for Social Sciences) 15.0 for
Windows” software. The results were evaluated
with a 95% confidence interval, and p < 0.05 was
accepted as statistically significant.
RESULTS
Sociodemographic characteristics
A total of 31 subjects took part in the study. All sub-
jects were males, with an average age of 17.9 ± 1.5
(13.3-20.1) years. Applicants who were resident
within Izmir were 81.1%, those coming from out-
side of Izmir were 12.9%. The mothers of 96.8%,
and fathers of 93.5%, were alive; mothers’ cigarette
smoking rate was 58.1%, while fathers’ was 41.9%,
and fathers’ rate of consuming both alcohol and
cigarettes was 41.9%. Only 16.2% of the fathers
were not using a substance. The percentage of sub-
jects living at home with their family was 96.8%.
The rate of running away from home without in-
forming their family was 90.3%. The length of time































tween 1 to 45 days, with a mean of 8.6 ± 12.4 days.
Upon investigating their educational status, 90.3%
of the subjects were found to be not attending
school. The years of education that the subjects had
had were between 1 and 13, with a mean of 7.8 ±
2.8 years. Until the time of admission to EGEBAM,
93.5% of the subjects had worked in an occupation
related to some volatile substance. The family in-
come of 16% of subjects was 0-400 euros/month, of
67% was 400-700 euros/month, and of 16.1% was
≥ 700 euros/month. 
In the study group, 5 subjects (16.1%) reported hav-
ing had a suicide attempt. There were 26 (64.5%)
subjects with a criminal record, and 6 of these
(19.3%) had done time in prison because of sub-
stance abuse. 74.2% of the subjects reported previ-
ously having gotten medical help because of sub-
stance abuse. Occurrence of inpatient treatment be-
cause of substance addiction was between 1 and 6
times, with a mean of 1.9 ± 1.4. Except for glue
(trademark: Bally) and paint thinner, no other in-
halant abuse was found. The rate of Bally abuse was
80.6%, paint thinner 6.5%, and those who abused
both were 12.9% (Table I). 
Cigarette smoke was the substance most used along
with inhalants. After cigarettes, followed hashish,
ecstasy, benzodiazepine, alcohol and cocaine ad-
dictions. Cigarette abuse rate was 3.2%, addiction
rate 87.1%; hashish abuse rate 29%, addiction rate
54.8%; ecstasy abuse rate 25.8%, addiction rate
29%; benzodiazepine abuse rate 19.4%, addiction
rate 19.4%; alcohol abuse rate 51.6%, addiction
rate 16.1%, cocaine abuse rate 9.7%, and addiction
rate 3.2% (Table II). The mean age of onset of VSA
was 14.2 ± 2.2 (9-18) years. The age of onset of
abuse of the other substances was: 11.8 ± 2.7 (7-16)
years for cigarettes, 14.2 ± 2.0 (10-18) years for al-
cohol, 14.5 ± 2.1 (10-19) years for hashish, 14.7 ±
1.6 (12-17) years for benzodiazepine, 15.0 ± 2.6
(12-18) years for cocaine, and 15.2 ± 1.4 (12-17)
years for ecstasy.
The duration of VSA varied between 1 and 9.2
years, with a mean of 3.7 ± 1.7 years. In terms of
the duration of abuse, and the amount of substance
abused daily, the subjects with an abuse history of
1-2 years were daily abusing a mean of 4.0 ± 1.4
tubes of inhalants, those with 2-3 years were abus-
ing a mean of 4.1 ± 6.8 tubes, those with 3-4 years
were abusing a mean of 5.6 ± 2.3 tubes, those with
4-5 years were abusing a mean of 5.7 ± 4.0 tubes,
and those with 5 years were abusing 6.1 ± 5.6
tubes.
Evaluation with Yeniden Inhalant Abuse Severity
Scale (YUKUD)
YUKUD scale points ranged between 10 and 50,
with a mean of 31.0 ± 9.7. Although YUKUD scale
points had a weak negative correlation with the age
of onset of VSA (as YUKUD scale points increase,
age of onset decreases), this was not statistically sig-
nificant (p > 0.05). There was no significant rela-
tionship between the duration of attending school,
the length of time of living on the streets, and the
YUKUD scale points (p > 0.05). Although the
YUKUD scale points of those whose mothers
smoked cigarettes were found to be higher than for
those with non-smoker mothers, that was not a sta-
tistically-significant difference (p > 0.05). Father's
substance/use status was not significantly related to
the YUKUD scale points (p > 0.05). Although the
YUKUD scale points of the subjects who had run
away from home were higher than for those who
had not run away, that was not statistically signifi-
cant (p > 0.05). Also no significant difference was
detected in YUKUD scale points for subjects with
respect to having suicide attempts or having a crim-
inal record (p > 0.05). 
Respiratory system findings
As shown in Table III, the most frequent symptom
among the subjects was nasal congestion (45.2%).
Following this was: sputum (38.7%), exercise intol-
erance (32.3%), cough (22.6%), chest pain (16.1%),
shortness of breath (9.7%), tachypnea (9.7%),
wheezing (6.4%), sneezing (6.4%), and runny nose
TABLE I: THE DISTRIBUTION OF INHALANTS BEING ABUSED
AMONG THE STUDY SUBJECTS    
Volatile Substance Abuse n (%)
Paınt thinner 2  (6.5%)
Glue (trademark, Bally) 25  (80.6%)
Thinner + Bally 4  (12.9%)
TABLE II: THE AGE OF ONSET, AND THE RATES OF ABUSE AND ADDICTION, FOR EACH SUBSTANCE    
Substance name Age of onset (years) Abuse Addiction
Mean ± SD n (%) n (%)
Cigarette smoke 11.85 ± 2.69 1  (3.2%) 27  (87.1%)
Inhalant 14.16 ± 2.16 0 31  (100%)
Alcohol 14.23 ± 1.97 16  (51.6%) 5  (16.1%)
Hashish 14.46 ± 2.06 9  (29.0%) 17  (54.8%)
Benzodiazepine 14.75 ± 1.65 6  (19.4%) 6  (19.4%)
Cocaine 15.0 ± 2.58 3  (9.7%) 1  (3.2%)
Ecstasy 15.17 ± 1.42 8  (25.8%) 9  (29.0%)
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(6.4%). No symptoms were present amongst the
control group, as this group was selected from ado-
lescents without health problems.
Pulmonary function tests
The groups' age, weight, and height distributions
were not statistically significantly different 
(p > 0.05) (Table IV). The mean FEV1 value was 3.8
± 0.6 L in the patient group, while 4.2 ± 0.6 L in the
control group, and there was a statistically signifi-
cant difference between them (p < 0.05).
Calculated as a percentage of the predicted value,
the mean FEV1 of the patient group was 97.7 ±
13.8%, while the control group's was 103.4 ±
10.7%, and there was no statistically significant dif-
ference between them (p > 0.05).
The mean FVC values were 3.90 ± 0.62 L in the pa-
tient group compared to 4.3 ± 0.7 L in the control
group, the difference between the two groups being
statistically significant (p < 0.05). Calculated as a
percentage of the predicted value, the mean FVC
was 84.0 ± 11.7% in the patient group vs. 88.7 ±
10.9% in the control group, and there was no statis-
tical significance between the two (p > 0.05). The
mean FEV1/FVC ratio was 97.1 ± 4.7 in the study
group vs. 97.6 ± 3.3 in the control group.
Calculated as a percentage of the predicted value,
the mean FEV1/FVC was 117.0 ± 5.5% in the pa-
tient group vs. 117.4 ± 4.5% in the control group.
None of the numerical or percentage values
showed a significant difference (p > 0.05). The aver-
age peak expiratory flow (PEF) value, was 6.85 ±
1.08 L/sec in the patient group, compared to 9.5 ±
0.8 L/sec in the control group. Calculated as a per-
centage of the predicted value, the average PEF was
80.4 ± 17.0% in the patient group vs. 110.2 ±
17.9% in the control group. Both numerical and
percentage values were found to be lower in the
study group, with a high level of statistical signifi-
cance (p < 0.01). The average mean expiratory flow
(MEF)25-75 value was 4.9 ± 1.2 L/sec in the study
group compared to 6.3 ± 1.2 L/sec in the control
group. Calculated as a percentage of the predicted
value, the average MEF25-75 was 114.6 ± 22.9% in
the study group, and 138.9 ± 32.1% in the control
group. Both numerical and percentage values were
found to be lower in the study group, with a high
level of statistical significance (p < 0.01) (Table V).
Twelve (41.4%) subjects in the study group and 2
(15.4%) subjects in the control group had a reduc-
tion of 20% or more in FVC levels which was not
statistically significant (p > 0.05). There was no sta-
tistically significant relationship (p > 0.05) between
a reduction of ≥ 20% in FVC, and the age of onset,
nor duration of VSA, nor total amount of abused
substances. There was no statistically significant re-
lationship between pulmonary system complaints
and a reduction of ≥ 20% FVC (Table VI).
The study group was divided into two subgroups,
according to their predicted FVC values being be-
low (group 1) vs. above (group 2) 80%. The HRCT
findings of the two subgroups showed no statistical-
ly significant difference in the rates of small airways
disease, nor subpleural nodules (p > 0.05); but 
centrilobular nodule and atelectasis rates were sig-
nificantly higher in the first group (p < 0.05). There
was statistically a highly significant difference 
(p < 0.01) between having an abnormal finding in
HRCT and having a reduction of ≥ 20% in FVC.
Comparing the scintigraphy findings, there was no
significant difference concerning perfusion or venti-
lation disorders (p > 0.05) (Table VII).
DISCUSSION
A "substance" is any chemical which is consumable
by various means, and influences sensations, per-
ceptions, cognition, or other brain functions with a
likelihood of abuse and addiction. "Substance
abuse" is the recurring use of a substance within a
year, which may cause probable social and/or legal
problems or physical risk. "Substance addiction" is
a broad concept of addiction, which reflects the
TABLE III: DISTRIBUTION OF RESPIRATORY-RELATED COM-
PLAINTS AMONGST GROUP (N = 31) OF VOLATILE 
SUBSTANCE ABUSERS
N %
Nasal congestion 14 45.16
Sputum 12 38.71
Exercise intolerance 10 32.26
Coughing 7 22.58
Chest pain 5 16.13




Runny nose 2 6.45
TABLE IV: DEMOGRAPHIC CHARACTERISTICS OF THE GROUPS    
Study group (n = 31) Control group (n = 13) p•
Mean ± SD Mean ± SD
Age (years) 17.94 ± 1.52 18.78 ± 0.64 0.066
Weight (kg) 67.88 ± 14.16 64.61 ± 8.54 0.455
































substance having taken a central role in the per-
son's life, the individual's having lost the control
over his/her own substance use, and the existence
of substance-related physical and psychological
problems [10]. Both in Turkey and in the rest of the
world, the rates of use of stimulants and sedatives
are increasing fast, and the age of onset of VSA is
becoming terrifyingly younger. A long-term use of
inhalants is known to have harmful effects on many
systems, and primarily on the central nervous sys-
tem. But the literature on the effects on the respira-
tory system has been limited to a few case reports.
In this study, all of the subjects were males with an
age range of 13-21 years. This selection was be-
cause of the policy of the Ege University Child and
Adolescent Addiction Investigation and Practice
Center (EGEBAM), that admits only males for 
inpatient treatment. Investigating the literature also
points to males as the more likely to abuse volatile
substances [11,12]. EGEBAM started its service in
September 2003. Listing the applications to the
EGEBAM outpatient service between September
2003 and September 2005, 88.5% of the subjects
are found to be males [13]. 
In Turkey, the widely used volatile substances are
paint thinner and glue [3]. Glues contain less
toluene than paint thinner, and the abusers report
that glue gives more euphoria and hallucinogenic
effects, while paint thinner has more sedative and
anesthetic effects [14]. In conducted studies, it was
found that those who live on the streets prefer paint
thinner, while those who live with their family pre-
fer glue [15,16]. This situation may be explained by
the different motivation behind the abuse: leisurely
pursuit in the case of those who live with their fam-
ily, while for those who live on the streets the pur-
pose is to stay alive, enduring the cold and danger
of the streets, and to lessen the pain of hunger. In
this study, the volatile substances which were re-
ported to be abused were only Bally and thinner,
Bally abuse rate being 80.6%, thinner 6.5%, and
their being used together 12.9%. This marked differ-
ence between Bally and thinner usage might be due
to the fact that almost all of the subjects were living
with their families.
Vega et al. [11] have stated that, in the development
of volatile substance addiction, a history of sub-
stance abuse in the family and parents' smoking
TABLE V: EVALUATING THE PULMONARY FUNCTION TESTS FOR THE STUDY AND CONTROL GROUPS    
Study group (n = 29) Control group (n = 13) P•
Mean ± SD Mean ± SD
FEV1 (L) 3.78 ± 0.59 4.23 ± 0.59 0.029*
FEV1 (%) 97.75 ± 13.85 103.38 ± 10.75 0.202
FVC (L) 3.90 ± 0.62 4.35 ± 0.71 0.046*
FVC (%) 84.03 ± 11.66 88.69 ± 10.88 0.229
PEF (L/secec) 6.85 ± 1.08 9.54 ± 0.85 0.001**
PEF (%) 80.44 ± 16.97 110.23 ± 17.88 0.001**
FEV1/FVC 97.10 ± 4.75 97.61 ± 3.30 0.727
FEV1/FVC (%) 117.00 ± 5.55 117.37 ± 4.53 0.866
MEF25-75 (L/sec) 4.94 ± 1.22 6.35 ± 1.21 0.001**
MEF25-75 (%) 114.65 ± 22.95 138.92 ± 32.15 0.008**
•: Student's t-test.
*p < 0.05. 
**p < 0.01.
TABLE VI: COMPARING THE REDUCTION IN FVC WITH THE PULMONARY SYSTEM COMPLAINTS IN THE STUDY GROUP    
FVC ≤ 80 % (n = 12) FVC > 80 % (n = 17) p•
n % n %
Coughing 2 16.7 4 23.5 1.000
Shortness of breath 3 25.0 0 0 0.060
Tachypnea 0 0 2 11.8 0.498
Wheezing 0 0 1 5.9 1.000
Chest pain 2 16.7 2 11.8 0.706
Sputum 4 33.3 6 35.3 0.913
Exercise intolerance 5 41.7 4 23.5 0.298
Sneezing 0 0 2 11.8 0.498
Runny nose 0 0 2 11.8 0.498
Nasal congestion 5 41.7 8 47.1 0.774
•: Fisher’s Exact test, where Chi-Square test would be necessary. 
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cigarettes have an important influence. Volatile sub-
stance abusers have quite high rates of substance
use in their family. In our study there were no sub-
stances used in the subjects' families except for
mothers smoking cigarettes and fathers both smok-
ing cigarettes and consuming alcohol. Alcohol con-
sumption rate was 41.9%, while cigarette smoking
rate was 58.1% for mothers, and 83.8% for fathers.
Only 16.2% of the fathers were not using any sub-
stances.
In the case histories of inhalant abusers, a charac-
teristic that is reported in the literature is trouble in
their education, such as truancy, failure in school,
and/or dropping out without completing their edu-
cation [17,18]. In a study by Ögel et al. [19], 86.2%
of the subjects reported having dropped out of
school, and the average length of education was 7.3
years. In a study conducted by Altenkirch and
Kinderman [20], 38% of the volatile substance
abusers had attendance to a lower grade, and 90%
dropped out of school, without completing their 9-
year education toward a diploma. In our study, in-
vestigating educational status, 90.3% of the sub-
jects were found to be not attending school. The
years of education completed by the subjects varied
between 1 and 13, similar to the rates reported in
the literature, and the average length of education
was 7.80 ± 2.79 years.
Shoemakers (production or repair), furniture pro-
ducers, printers, coiffeurs, painters, personnel of
gas-oil stations, car/motorcycle/bicycle repairers,
dry-cleaners, those working in petroleum refineries
and related industries, personnel of factories using
or producing inhalant-solvents, personnel of drug
factories, and personnel working in medical fields
constitute the increased-risk groups for volatile sub-
stance addiction and abuse [21]. A comprehensive
study conducted in Mexico by Conyer et al. [22]
found male gender, low socio-economic status, and
work conditions as the primary risk factors toward
VSA. Likewise, in our study, 93.5% of the subjects
had previously worked in a job where there was a
high risk of encountering volatile substances. And
this suggests a solution against the problem of
volatile substance addiction, pointing out the im-
portance of prohibiting children from working in
workplaces where they might encounter inhalants.
Substance addicts have high rates of attempting and
committing suicide [11,23]. Ögel et al. [19] found
that 16.7% of inhalant abusers had suicide attempts
in their history. In our study, this rate was similar:
16.1%.
There are a few fundamental characteristics which
differentiate inhalant abusers from the abusers of
other substances. Aggressiveness, committing sub-
stance-abuse related crimes, running away from
home, harming oneself, and truancy, are more
prevalent among these subjects than in adolescents
who abuse other substances [24-29]. Concerning
the effects of inhalants on the brains of addicts, cog-
nitive problems are generally seen [30,31].
Tolerance against inhalants develops fast and easily,
and clinically-significant withdrawal symptoms do
not occur [31]. To this list, when the adolescents liv-
ing on the streets are added, there surfaces the need
for questionnaire forms and scales to assess the ad-
diction intensities of inhalant abusers [14].
Therefore, in 2005, Ögel et al. [32] developed
YUKUD (Yeniden Inhalant Abuse Severity Scale). In
that study, which was conducted with 50 volatile
substance addict adolescents, the mean scale total
score of the subjects was 61.4 ± 10.4. Similarly, in
our study, the YUKUD scale was used to investigate
the substance abuse intensity of the subjects.
Obtained total scores varied between 10 and 50,
and the average was 31.1 ± 9.7. No relationship
was found between abuse intensity, and the age of
onset of VSA, school attendance duration, or fa-
ther's substance abuse. As the duration of living on
the streets increases, the abuse intensity also in-
creases, and these correlate almost at a statistically
significant level. The YUKUD scores for those who
had run away from home, had suicide attempts, had
trouble with the law, and whose mothers were
smoking cigarettes, were found to be higher, al-
though not significantly so.
TABLE VII: COMPARING THE REDUCTION IN FVC, WITH HRCT AND SCINTIGRAPHY FINDINGS    
FVC
≤ 80% (n = 8) > 80 % (n = 15) p•
HRCT
Small airways disease 0 2 (13.3%) 0.280
Subpleural nodule 4 (50.0%) 2 (20.0%) 0.136
Centrilobular nodule 2(25.0%) 0 0.043*
Atelectasis 2 (25.0%) 0 0.043*
Normal 1 (12.5%) 11 (73.3%) 0.009**
Scintigraphy
Perfusion disorder 3 (33.3%) 4 (28.6%) 1.000
Ventilation disorder 1 (11.1%) 3 (25.0%) 0.603


































Coughing, shortness of breath, and wheezing are
the most frequent complaints of inhalant abusers
[6]. In a study conducted in the Philippines with 31
street children, the most frequently observed respi-
ratory system complaints were listed as shortness of
breath (38.7%), coughing (35.5%), and runny nose
(29%) (33). Hellguist et al. [34], after analysing
histopathologically the nasal biopsies taken from 10
painters who had occupational exposure to toluene
and isobutyl acetate, reported that they encoun-
tered no normal mucosa. In a study conducted in
Turkey, animals which were subjected to thinner in-
halation had mucosal deformation, including in-
flammation and cilia loss in their nasal and larynx
mucosa. In our study, the most frequently observed
symptom was nasal congestion (45.2%). Following
this came, in descending order of prevalence: spu-
tum (38.7%), exercise intolerance (32.3%), cough-
ing (22.6%), chest pain (16.1%), shortness of breath
(9.7%), tachypnea (9.7%), wheezing (6.4%), sneez-
ing (6.4%), and runny nose (6.4%). 
In the literature, studies investigating the pulmonary
functions of inhalant abusers are quite rare. Studies
which investigate VSA-related morbidity and mor-
tality are mostly limited to investigating the occupa-
tional exposure to solvents in industrial settings [8].
According to the U.S. Occupational Health and
Safety Administration (OSHA), the safe limit allow-
able for solvents is 200 parts per million (ppm) for
toluene, and 100 ppm for trichlorethylene. But, the
concentration of toluene inhaled from a bag which
contains Bally might reach 10,000 ppm [3,8].
Schikler et al. [35], compared the pulmonary func-
tion tests of 42 inhalant addicts between the age of
11-31 years, and 20 healthy controls aged between
10-26 years, and found that the residual volumes of
the addicts were significantly higher than those of the
controls. Panacinar emphysema was observed in the
lung tissues obtained from 3 subjects who were
known as inhalant addicts and who had died because
of trauma or accident, and this finding was proposed
to explain the increase in residual volume [35]. 
In the literature, we found a single study addressing
the relationship between VSA and respiratory func-
tions. This study by Pogoy et al. [33] observed low
FVC values indicating restrictive ventilatory pattern
in 13 (41.9%) of the 31 street children between
ages of 7-18 (mean age 14 ± 2) years, and with a
mean duration of drug use of 2.6 ± 2.5 years. The
FEV1 values of all of their subjects were normal. In
our study, the highest obtained FEV1 and FVC values
of the inhalant addicts were significantly lower than
those of the control group (p < 0.05). PEF and
MEF25-75 values of the study group were lower than
in the control group, at a high level of statistical sig-
nificance (p < 0.01). FEV1/FVC ratio was not differ-
ent between the groups (p > 0.05). Calculating the
percentage of reduction relative to the predicted
values, 12 (41.4%) subjects in the study group were
found to have low FVC values, indicating restrictive
ventilatory pattern. FEV1 of 2 subjects (6.89%) was
reduced 20% or more. Restrictive ventilatory pat-
tern was more prevalent in the study group, but not
at a statistically significant level. Therefore, VSA
might be causing decreases in lung volumes and
flow velocities and, similar to the case of Pogoy et
al.’s study, this might be related to a restrictive ven-
tilatory pattern. In our study, relations between a re-
duction of ≥ 20% in FVC and age of onset of VSA,
duration of abuse, total amounts of abused in-
halants, and respiratory system complaints were not
statistically significant (p > 0.05). 
In the literature, we found no study evaluating the
radiological findings of inhalant abusers. Dividing
the study group into two subgroups according to
their reduction in FVC, i.e. those who have vs. do
not have restrictive ventilatory pattern, and then
comparing their HRCT findings, small airways dis-
ease and the observed subpleural nodules rates we
found no statistically significant differences be-
tween the two subgroups (p > 0.05), while the rates
of observed centrilobular nodules and atelectasis
were significantly higher in the first subgroup 
(p < 0.05). Restrictive ventilatory pattern was corre-
lated with abnormal findings in HRCT, with a high
level of statistical significance (p < 0.01). In view of
the findings observed in the lung scans of all of our
inhalant addicted subjects, those who have a low
FVC at spirometry should undergo HRCT.
In a study which compared the ventilation scintigra-
phies of 28 car painters who had occupational ex-
posure to toluene, and 13 healthy controls, it was
stated that Tc-99m diethylenetriaminepentaacetate
(DTPA)'s clearence from lungs was slower in car
painters than in controls [36]. In another study,
which was conducted with 10 painters and 10
healthy controls, occupational exposure/subjection
to toluene was shown not to influence bronchoalve-
olar epithelial permeability. In our study, we per-
formed ventilation scintigraphy in 21 volatile sub-
stance addicts, and 3 (14.2%) of the subjects were
found to have hypoventilation in the right apical re-
gion, while 1 (4.7%) had retention in central airways.
No relationship was found between a reduction in
FVC, and perfusion and ventilation disorders.
Inhalation of volatile substances for their psycho -
active properties has a very long history and has
been widely detected all around the world in differ-
ent age groups, including very young people. As
volatile substance abuse is a social problem, it re-
quires a social response. VSA will best be addressed
by addressing the social problems facing young
people. Respiratory complications of volatile sub-
stances are well noted to clinicians as a clinical ob-
servation, but have not been documented or studied
adequately in clinical research. This study has
shown a positive correlation between volatile sub-
stance abuse and the development of restrictive
ventilatory pattern. But further evaluation of long-
term effects (more than 10 years) of volatile sub-
stances, and more comprehensive studies are need-
ed to enable more precise conclusions to be drawn. 
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